Virologic outcomes in early antiretroviral treatment: HPTN 052

• Main Authors: Susan H. Eshleman, Ethan A. Wilson, Xinyi C. Zhang, San San Ou, Estelle Piwowar-Manning, Joseph J. Eron, Marybeth McCauley, Theresa Gamble, Joel E. Gallant, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James G. Hakim, Ben Kalonga, Jose H. Pilotto, Beatriz Grinsztejn, Sheela V. Godbole, Nuntisa Chotirosniramit, Breno Riegel Santos, Emily Shava, Lisa A. Mills, Ravindre Panchia, Noluthando Mwelase, Kenneth H. Mayer, Ying Q. Chen, Myron S. Cohen, Jessica M. Fogel
• Format: Journal
• Published: 2018
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017113091&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/47172
• Institution: Chiang Mai University

© 2017 Informa UK Limited, trading as Taylor & Francis Group. Introduction: The HIV Prevention Trials Network (HPTN) 052 trial demonstrated that early antiretroviral therapy (ART) prevented 93% of HIV transmission events in serodiscordant couples. Some linked infections were observed shortly a...